2Indexed trials
drug · Product Intelligence
Albendazole
Pipeline Intelligence
Albendazole: 2 indexed trials, 2 sponsors; 0 linked Orange Book patents and 10 FDA-linked events where matched.
2Sponsors
0Orange Book patent links
10FDA-linked events
Development evidence
NCT00004403Johns Hopkins University · epilepsyNA
NCT00441285Universidad Peruana Cayetano Heredia · epilepsyPHASE2, PHASE3
FDA / patent evidence
Orange Book match found; no listed patent relation was retained for this product match.
Regulatory context
FDA_APPROVALALBENDAZOLE · 2024-09-04
FDA_APPROVALALBENDAZOLE · 2021-01-26
FDA_APPROVALALBENDAZOLE · 2021-01-21
FDA_APPROVALALBENDAZOLE · 2020-06-10
FDA_APPROVALALBENDAZOLE · 2019-05-20
FDA_APPROVALALBENDAZOLE · 2019-05-14
FDA_APPROVALALBENDAZOLE · 2018-12-14
FDA_APPROVALALBENDAZOLE · 2018-12-07
FDA_APPROVALALBENDAZOLE · 2018-09-21
FDA_APPROVALALBENZA · 1996-06-11
FDA Orange Book coverage is U.S.-specific and is not a substitute for worldwide patent or regulatory review.